MetaCap

Solana Company Class A (HSDT)

NASDAQ: HSDTHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

1.49-0.17 (-10.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

HSDT stock chart

Technical analysis

Key statistics

All statistics
Market cap
$93.70M
EPS (TTM)
$87.97
52-week range
1.19 – 4.36
Day range
1.49 – 1.63
Volume / Avg
1.14M / 579.67K
Beta
—

52-week range

$1.19$4.36

HSDT stock today

Solana (HSDT) closed at $1.49 on Nov 20, down 10.24% (-$0.17), versus the S&P 500's 3.70% decline. Shares are 65.8% below their 52-week high of $4.36, set on Dec 3, 2025 and 25.7% above the 52-week low of $1.19, near the bottom of the past year's range. HSDT is down 48.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 53.7%.

Solana trades at 0.0x its trailing twelve-month earnings per share of $87.97.

Summary generated from market data by MetaCap's automated system. Methodology

About Solana

Company profile

Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications. It also focuses on neurological wellness.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Mr. Choon Wee Chee
Headquarters
Newtown, PA
Employees
21

Financial highlights

Full financials

In fiscal 2025, Solana generated $6.0 million in revenue, up 1057.1% from fiscal 2024. Solana reported a net loss of $40.9 million, compared with a loss of $11.7 million a year earlier. Gross margin was 91.7% (up from -11.9%) and operating margin -4052.5%.

Solana annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$6.02M$520.00K$644.00K$787.00K$522.00K
Growth+1057.12%-19.25%-18.17%+50.77%-21.03%
Net income$-40.89M$-11.74M$-8.85M$-14.07M$-18.13M
EPS (diluted)$-1.85$-3,282.26$-14.56$-52.13$-7.38

Analyst forecast

Forecast

Consensus (2 analysts)

strong_buy

Avg. price target

$3.50+134.90%

  • Strong buy 1
  • Buy 1
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $3.00High $4.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 11, 2026
EPS actual vs est.
$-32.89 vs $-0.01
Surprise
-328800.00%

HSDT news

All HSDT news

Solana peers

Health Care sector
HSDT peer companies
CompanyPrice% ChgMarket capCompare
STXSStereotaxis Inc.0.9422-6.71%$95.03Mvs HSDT
VANIVivani Medical Inc.1.14+4.59%$102.83Mvs HSDT
FOCLEDAP TMS S.A. ADR2.61-7.45%$123.25Mvs HSDT
NRXSNeuraxis Inc.4.22-6.22%$59.90Mvs HSDT
HYPRHyperfine Inc. Class A0.5465+4.27%$57.96Mvs HSDT
OMOutset Medical Inc.2.81-3.44%$53.03Mvs HSDT
POCIPrecision Optics Corporation Inc.4.12+1.41%$45.30Mvs HSDT
ECORelectroCore Inc.4.42-8.87%$40.78Mvs HSDT

Indexes, lists and sector

Solana stock FAQ

What is Solana's stock price today?

HSDT last traded at $1.49 as of Nov 20, 4:00 PM EST, down 10.24% on the day. Prices are delayed at least 15 minutes.

Does Solana pay a dividend?

No. Solana does not currently pay a regular cash dividend.

What is HSDT's P/E ratio?

HSDT trades at a trailing P/E ratio of 0.02.

Who is Solana's CEO?

Mr. Choon Wee Chee is the chief executive officer of Solana Company Class A, which has about 21 employees.

Has HSDT ever split its stock?

Yes. The most recent HSDT stock split was a 1-for-50 split on Jul 1, 2025, one of 5 splits on record.

What is the HSDT 52-week high?

The 52-week high for HSDT is $4.36 and the 52-week low is $1.19. The stock is currently 65.8% below its high.

Compare HSDT